B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma
Saved in:
Main Authors: | Amber Loren O. King, BA (Author), Fatima N. Mirza, MPH (Author), Julia M. Lewis, PhD (Author), Kacie R. Carlson, PA (Author), Scott Huntington, MD, MPH (Author), Francine M. Foss, MD (Author), Michael Girardi, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of bullous lesions in cutaneous T-cell lymphoma
by: Suzanne Xu, BS, et al.
Published: (2023) -
A rare presentation of cutaneous T-cell lymphoma mimicking morphea
by: Beverly Yu, BA, BS, et al.
Published: (2023) -
Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019
by: Michael Girardi, et al.
Published: (2024) -
Nivolumab-associated cutaneous T-cell lymphoma
by: Jennifer A. Marks, MD, et al.
Published: (2021) -
A poisoned cherry: Migratory cutaneous intravascular large B-cell lymphoma with subsequent systemic nodal lymphoma.
by: Michael Weingarten, BA, et al.
Published: (2020)